Training-Time Domain Transfer for Generator-Free Diagnostics on Novel Modalities in Computational Pathology
Organizations: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden · Harvard Medical School, USA · Department of Pathology, Stavanger University Hospital, Norway · Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Norway ·
Abstract
Novel imaging modalities promise improved diagnostics, but AI development is constrained by scarce training data. Inference-time domain transfer can address this by mapping novel modalities to established ones, enabling reuse of existing diagnostic models. However, this introduces hallucination risks, computational overhead, and regulatory complexity. Inspired by sim-to-real transfer, we propose training-time domain transfer, generating synthetic target-domain training data from archived routine samples to enable direct diagnosis on real inputs without inference-time generation. Using unstained prostate histopathology as a proof-of-concept, we compare this approach with inference-time virtual staining and conventional H&E-based cancer detection. Training-time transfer achieved higher concordance with the conventional benchmark than virtual staining for both raw (Cohen's =0.59 vs. 0.37; Gwet's AC1=0.73 vs. 0.29) and deparaffinized tissue (=0.66 vs. 0.61; AC1=0.73 vs. 0.64), supporting its potential for emerging diagnostic modalities.
Figures & tables
| STHLM3-SFH | Diagnostic training | Diagnostic tuning | |||||||
| Train raw | Train DP | Test | STHLM3 | SUH | STG | STHLM3 | KUH | RUMC | |
| Patients | 250 | 117 | 67 | 2,711 | 710 | 70 | 24 | 73 | 72 |
| Slides | 250 | 117 | 79 | 29,527 | 4,589 | 247 | 276 | 330 | 195 |
| WSIs | 250 | 117 | 79 | 32,609 | 4,591 | 247 | 276 | 330 | 195 |
| Age 49 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 4 (0.1) | 13 (1.8) | 0 (0.0) | 0 (0.0) | 2 (2.7) | – |
| Age 50–54 | 15 (6.0) | 6 (5.1) | 8 (11.9) | 216 (8.0) | 35 (4.9) | 1 (1.4) | 1 (4.2) | 5 (6.8) | – |
| Approach | AUC | F1 | Sens. | Spec. | AC1 | ||
|---|---|---|---|---|---|---|---|
| Real H&E | 0.970 | 0.933 | 0.875 | 1.000 | – | – | – |
| VS (raw) | 0.859 | 0.609 | 0.438 | 1.000 | 0.016 | 0.368 | 0.294 |
| VS (DP) | 0.932 | 0.804 | 0.672 | 1.000 | 0.161 | 0.606 | 0.643 |
| TTDT (raw) | 0.904 | 0.894 | 0.859 | 0.733 | 0.079 | 0.585 | 0.728 |
| TTDT (DP) | 0.922 | 0.860 | 0.766 | 0.933 | 0.142 | 0.658 | 0.728 |
Computational Pathology
Computational pathology uses algorithms to analyze digitized tissue images for diagnosis, prognosis, biomarker discovery, and clinical decision support.
See all 297 papers